MTN 009 Laboratory Logistics

Similar documents
VOICE (MTN-003) IT S ALL ABOUT THE ENDPOINTS. Edward Livant MT (ASCP), MPH University of Pittsburgh Medical Center MTN Network Laboratory

QA Processes That Work: Minimizing Errors During On-site Rapid HIV Testing

Investigating Unresolved HIV Status during Endpoint Confirmation. Kristen Cummings MTN Virology CORE

Unigold Recombigen HIV 1/2 Training for HIV Testing Sites. Updated: February 2018 Cicely Richard Office of HIV/AIDS

MTN 015 SPECIMEN REVIEW. Gabriel Banda Core Lab Supervisor UNC Project, Lilongwe

BLOOD COLLECTION GUIDELINES

ANTIBODY SCREENING by Uni-Gold Recombigen HIV

Specimen Collection Policies

Section 9. Laboratory Considerations

Specimen Management PHRU LAB

Follow-up Visit Procedures MTN-009

Blood Lead Filter Paper Collection. Regional Pathology Services University of Nebraska Medical Center

HOPE Follow-Up Algorithm: Unusual Cases. Urvi Parikh, PhD MTN Virology Core Regional Meeting Lab Breakout Sept 27-28, 2016, Cape Town

DETERMINE SPECIMEN REQUIREMENTS HIV-1/2 Ag/Ab Combo TESTING PROCEDURE

Collection of Dried Blood Spots from Infants for Diagnosis of HIV by DNA PCR. MOH Regional Trainings March 2013

9.1 Overview and General Guidance This section contains information on the laboratory procedures performed in MTN-035.

Management of Central Venous Access Devices. Blood Glucose Monitoring

MTN 005 Laboratory Training. Lorna Rabe MTN Network Laboratory Magee-Womens Research Institute Pittsburgh, PA

Evaluation of Dried Blood Spots (DBS) for Human Immunodeficiency Virus (HIV-1) Drug Resistance Testing

Step-by-Step Instructions For OraQuick HCV Rapid Antibody Test

HIV Diagnostic Testing

To provide you with necessary knowledge and skills to accurately perform 3 HIV rapid tests and to determine HIV status.

If you notice discrepancies between the package insert and the WSLH instructions, follow the WSLH instructions!

Precision ceedpro. Online Training for. Glucometer & Capillary Collection

Diagnostic Tests for HIV

Tips for Training New Customers

New tools for diagnosis and surveillance

Skills workshop: Screening tests for syphilis

TEST REQUEST INFORMATION- VIROLOGY

MARSHALLTOWN MEDICAL & SURGICAL CENTER Marshalltown, Iowa

New Generation of Nucleic Acid Testing. Michele Owen, Ph.D Division of HIV/AIDS Prevention Centers for Disease Control & Prevention

Measuring Impact PHIA Findings from Malawi, Zimbabwe, and Zambia

Evolution of HIV Diagnostics. Goals for the 2010 Conference. Bernard M. Branson, M.D. CDC Division of HIV/AIDS Prevention

2/10/2015. Experiences and opportunities in the use of dried blood spot specimens in resource limited settings. Presentation

Title: Abbott Optium Xceed Glucose Meter Effective date: 16/05/2011. Summary of Significant Changes at this Revision. SOP updated.

OraQuick ADVANCE Rapid HIV-1/2 Antibody Test Customer Letter

MARSHALLTOWN MEDICAL & SURGICAL CENTER Marshalltown, Iowa

The role of continuous glucose monitoring as a self-monitoring behaviour change tool to enhance glycaemic control in individuals with type 2 diabetes

Summary of Significant Changes at this Revision. Items Required

2018 HIV and HCV Diagnostic Testing Survey

TESTS, REF TESTS)

HIV Update in Laboratory Testing. Patricia Slev, PhD, D(ABCC)

Opportunities Created by Diagnostic HCV and HIV Nucleic Acid Tests

Tips for Successful Venipuncture

Section 13. Laboratory Considerations

WHO Prequalification of In Vitro Diagnostics PUBLIC REPORT. Product: DPP HIV 1/2 Assay WHO reference number: PQDx

MÉDECINS SANS FRONTIÈRES VIRAL LOAD TOOLKIT AN IMPLEMENTER S GUIDE TO INTRODUCING HIV VIRAL LOAD MONITORING

A Summary of Clinical Evidence

Precision Xtra Training

Micropathology Ltd. University of Warwick Science Park, Venture Centre, Sir William Lyons Road, Coventry CV4 7EZ

APHL/CDC HIV Demonstration Project Demonstration Project for HIV Nucleic Acid Testing (NAT) Referral Updated: January 2018

Supplementary Online Content

PROCEDURE. TITLE: Bedside Glucose Monitoring PC Laboratory. Issuing Department: Clinical Director Signature: Departments Involved:

Uni-Gold Recombigen HIV-1/2

Collection Instructions

Collection of Specimen

Section 9 Laboratory Consideration

WHO Prequalification of Diagnostics Programme PUBLIC REPORT. Product: Abbott RealTime HIV-1 (m2000sp) Number: PQDx

MTN-038 Laboratory Training. May Beamer, Michele Austin MTN Laboratory Center Magee-Womens Research Institute Pittsburgh, PA

Blood glucose monitor. MediTouch 2

Title: Glucose Testing: StatStrip Glucose Meter Page 1 of 6

Adventures in Discordance- HIV Testing

Instructions for Use HEMLIBRA (hem-lee-bruh) (emicizumab-kxwh) injection, for subcutaneous use

Abbott PXP Glucose Meters Resource: Lin Gustafson, MT(ASCP) Point of Care Coordinator, Laboratory

Advantages and disadvantages of different types of FDA-approved HIV immunoassays used for screening by generation and platform*

Geenius TM HIV 1/2 Supplemental Assay Instructions For Use

Learning Objectives. New HIV Testing Algorithm from CDC. Overview of HIV infection and disease 3/15/2016

HIV Testing in Children

WHO Prequalification of In Vitro Diagnostics PUBLIC REPORT. Product: Alere q HIV-1/2 Detect WHO reference number: PQDx

Alere INRatio 2 METHOD AND SAMPLE COLLECTION

FOR INFORMATIONAL USE ONLY

Phlebotomy Safety for All Ages

COMPLETE HIV 1/2 NAME AND INTENDED USE RESTRICTIONS SUMMARY AND EXPLANATION OF THE TEST

2.1 HIV antibody tests

Phlebotomy Procedure. SCOPE: This procedure is distributed to Central DuPage Hospital (CDH) and all off-site laboratories.

CoaguChek S System. Quick Reference Guide. This is a CLIA-waived System. Coagulation Testing with Fresh Whole Blood

Accu-Chek Inform II: Point of Care Glucose Testing. Sharp Healthcare 2014

EME. Self-Monitoring Blood Glucose System. Quick Reference Guide

WHO Prequalification of In Vitro Diagnostics Programme PUBLIC REPORT. Product: Uni-Gold HIV Number: PQDx Abstract

SUMMARY AND EXPLANATION OF THE TEST

HIV Serology Quality Assessment Program Summary for Panel HIVSER 2017Apr19

Trends in molecular diagnostics

1 st and 2 nd Generation EIA

ARCHITECT HIV Ag/Ab Combo: Moving HIV Diagnostics Forward in the U.S.

Robert G. Gish MD UC San Diego

Potential Effect of Alternative HIV Testing Algorithms on HIV Case Surveillance

Current Status: Active PolicyStat ID: Accu-Chek Whole Blood Glucose Testing Policy PURPOSE

Complicated viral infections

Collection of Blood Specimens. To provide instructions on correctly collecting blood specimens via vacutainer.

KINGSTON GENERAL HOSPITAL NURSING POLICY AND PROCEDURE

LeadCare BLOOD LEAD ANALYZER. Quick Reference Guide

SP.718 Special Topics at Edgerton Center: D-Lab Health: Medical Technologies for the Developing World

COMPLETE HIV 1/2 NAME AND INTENDED USE RESTRICTIONS SUMMARY AND EXPLANATION OF THE TEST

Screening and Diagnosis of Hepatitis Virus Infections

Vision and strategies to Increase Access to Innovative HIV Diagnostic Technologies. Willy Urassa. AMD STAKE HOLDERS MEETING 7-8 May 2013

Offering Testing for Hepatitis B and C in Primary Care

HIV Viral Load Quality Assessment Program Summary for Panel HIVVL 2018Oct26

CLIA Complexity for Whole Blood: WAIVED. Intended Use. Summary and Explanation

WHO Prequalification of In Vitro Diagnostics Programme PUBLIC REPORT. Product: Uni-Gold HIV Number: PQDx Abstract

Transcription:

MEDICAL RESEARCH COUNCIL OF SA HIV PREVENTION RESEARCH UNIT MTN 009 Laboratory Logistics RASHIKA MAHARAJ HPRU LABORATORY MANAGER

Testing Menu Finger stick Blood Samples HIV Rapid Tests* Venous Blood Samples HIV Western Blot* CD4 Positive T Cell Count* HIV RNA Viral Load HIV Resistance Testing Test for Recent Infection *Done locally in Durban

Testing Menu Urine Samples-None Pelvic Samples-None

Fingerprick Fingerprick blood: Fingerprick blood is collected in a SCHARP labelled 2ml Microtainer which contains EDTA, It is very important for the validity of the HIV rapid test, that at least 250 μl of fingerprick blood is collected and very well mixed. The blood will be collected as follows: the puncture must be on the palmar surface of the distal phalanx. The middle finger and ring finger are preferred. Holding the hand into warm water (+- 37 C) for a few minutes before puncturing the finger will stimulate the bleeding. If no warm water is available the finger should be first massaged very well. The skin-puncture site must be cleansed with a 70% aqueous solution of isopropanol (70% v/v). The skin is punctured with the use of a disposable lancet device, and is performed according to the operational instructions provided by the manufacturer. After the chosen site has been punctured, the first drop of blood should be wiped away with a gauze pad. A second drop will form over the puncture site. Hold the finger with the nail side upward, this will avoid that the blood runs under the nail. When the tip of the Microtainer touches this drop, blood will flow into the tube. Collecting the blood is easier if you rub with the finger on the tip of the microtainer.gently massage the patient finger to establish the flow of blood. Do NOT squeeze the patients finger. Blood flow from the puncture is enhanced by holding the puncture site downward and gently applying intermittent pressure proximal to the puncture site. After collecting a minimum of 250 μl of blood, the collection device is immediately capped and the blood is mixed well. PLEASE SEND TO ON SITE LAB FOR TESTING!

Fingerprick

HIV Rapid Testing A validation of finger stick HIV testing procedures will be done before study activation. This is to be compliant with DAIDS guidelines and to ensure that results from finger stick specimens will be comparable to venous samples.

HIV Rapid Testing-Cont. Validation Scheme: Population will be 20 HIV positive Individuals and 20 HIV negative individuals. All 40 people will be given fingerstick HIV rapid tests. For people with documented HIV status, no further testing required. For others, a venous sample will be drawn for confirmatory testing. [1 X 4ml EDTA]

HIV Rapid Testing-Cont. Validation Scheme: The Finger stick results will be compared to known results or confirmatory test results. If any results are discrepant, they will be investigated.

HIV Rapid Testing-Cont. The validation will also provide an opportunity to: Train and asses competency of the staff Set up work areas to accommodate Finger Stick HIV testing Develop work flows and identify trouble spots

Lab Workflow No lab tests during screening Lab tests commence after enrollment and administration of behavioral questionnaire.

Lab Workflow-cont. Step 1. Two rapid HIV tests: Determine and FDA approved Unigold (using blood from fingerstick) If both are negative, no further lab testing. If either rapid test or both are positive proceed to step 2.

Lab Workflow-cont. Step 2. Draw venous two 10 ml and plus one 2 ml EDTA tubes. Step 3. 2 ml tube is sent to BARC for CD4 T-Cell count for px that are pos or discordant Discordants: HIV Western Blot is sent to HPRU Central Routine Lab. Step 4. Separate and store all plasma from the two 10 ML EDTA tubes.

MTN 009 LAB WORKFLOW ENROLLMENT SPECIMENS AND LABORATORY PROCEDURES BLOOD STORAGE HIV VIRAL LOAD/GENOTYPE RESISTANCE & BED SAMPLE PREPARATION NEG/NEG REFER TO HIV PREVENTION TRIAL AT CLINIC 2 X RAPID HIV TESTS FINGER PRICK 1 X 2ML EDTA MICROTAINER POS/POS OR POS/NEG CD4 COUNT OUTSOURCED LAB 1 X 2ML EDTA VACUTAINER VIRAL LOAD/ GENOTYPE RESISTANCE/BED ON SITE/LDMS 2 X 10ML EDTA POS/NEG USE SAME 1 X 2ML EDTA SEND TO HPRU CENTRAL ROUTINE LAB FOR WESTERN BLOT ON SITE PLASMA STORAGE 2 x 10ml EDTA Aliquot 10 x 1 ml, Ship to LDMS who will store and ship to Network Core Virology Lab for HIV RNA, Genotype Resistance and BED testing OUTCOME OF RESULTS NL TO ADVISE POS NEG INDETERMINATE P.S PROCESS WITHIN 6 HOURS OF ramaharaj COLLECTION!!! V 1.0-refer to Chain of Custody Sop

HIV ALGORITHM

Testing done locally HIV Western Blot done at HPRU Central Routine Lab CD4 Count will be performed at BARC Durban

Testing at Network Lab The following tests will be done at Network Lab Viral load Standard Resistance Testing Sensitive Resistance Testing Test for Recency of Infection

Specimens for Shipment All done from EDTA plasma Stored at MRC within 8 hours of collection Stored in LDMS Shipments will be coordinated with MTN NL

Assays Used at Network Lab Test Assay Used Results Sent? Viral Load Abbott M2000 YES Standard Celera ViroSeq YES Resistance Test Sensitive Resistance Test In house method (Allele-Specific Real-time PCR) NO for research only BED Sedia BED HIV-1 Incidence EIA NO for research only

Viral Load and Resistance Tests Viral load Linear Range: 40 copies/ml 10,000,000 copies/ml Detects Subtypes A-H, Group O, Group N Standard Resistance Test Sequence based Reports all major mutations in the protease and reverse transcriptase genes in HIV Detection limit: 25% Sensitive Resistance Test Real time PCR based Gives % of an individual mutation Detection limit: 0.1%

Test for recency of infection (BED) In vitro quantitative enzyme immunoassay (EIA) Distinguishes recent HIV-1 infections from those that are long term by measuring HIV-1 specific IgG to total IgG IgG is a kind of antibody Research use only for surveillance studies Cannot be used for diagnosis or determining clinical outcome or treatment

BED Test Algorithm

Results Dissemination Results from resistance testing and Viral load will be sent back to MRC when complete from NL Results from sensitive resistance testing and BED recency assay are for research only and will not be sent back to MRC VL=2 DAYS 96/BATCH RT=6-8 WEEKS 10/BATCH=3MONTHS